Every research peptide, A to Z.

A breakthrough GLP-1 receptor agonist FDA-approved for weight management and type 2 diabetes. Demonstrated consistent 15% body weight reduction in clinical trials with cardiovascular benefits.

A dual GIP/GLP-1 receptor agonist delivering up to 22% weight loss in clinical trials. FDA-approved as Mounjaro and Zepbound, it outperforms single-pathway GLP-1 drugs.

A synthetic 15-amino-acid peptide derived from gastric juice protein, studied for accelerating healing of tendons, muscles, ligaments, and gut tissue. The most-searched research peptide globally.

An oral, non-peptide growth hormone secretagogue that elevates GH and IGF-1 levels for up to 24 hours. Popular for its convenience and effects on sleep, bone density, and body composition.

A coenzyme present in every living cell, critical for energy metabolism and cellular repair. NAD+ levels decline with age; replenishment is a cornerstone of modern longevity medicine.

A bioidentical analog of growth hormone-releasing hormone (GHRH). The bedrock of clinical anti-aging endocrinology, prescribed to safely restore youthful IGF-1 levels and improve sleep.

An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Unlike Viagra, PT-141 acts on the central nervous system to induce arousal rather than relying on blood flow.

A synthetic fragment of thymosin beta-4, studied for systemic tissue repair and anti-inflammatory effects. Often paired with BPC-157 as the 'Wolverine Stack' for injury recovery.

The cleanest growth hormone secretagogue available, delivering potent GH pulses without triggering hunger, cortisol, or prolactin spikes. The premier choice for year-round anti-aging protocols.

A potent alpha-MSH analog that stimulates melanogenesis for deep skin pigmentation with minimal UV exposure. Also known for side effects including appetite suppression and sexual arousal.

A naturally occurring copper-binding tripeptide that modulates over 4,000 human genes. The gold standard in dermal remodeling, wound healing, and systemic anti-aging research.

A modified GHRH analog that delivers intense, acute GH spikes mimicking natural nocturnal pulses. Almost always stacked with Ipamorelin for synergistic, non-suppressive GH release.

The most powerful weight loss peptide in clinical development, targeting three metabolic receptors simultaneously. Achieved 24.2% body weight reduction in Phase 2 trials.

A modified fragment of human growth hormone isolated to replicate fat-burning capability without altering IGF-1 levels or causing insulin resistance.

An FDA-approved GHRH analog with extraordinary specificity for reducing visceral adipose tissue. Originally designed for HIV-associated lipodystrophy.

A heptapeptide analog of the immunomodulator Tuftsin, developed by the Russian Institute of Molecular Genetics. Provides profound anxiety reduction with enhanced mental clarity, without sedation or addiction risk.

A neuro-stimulatory heptapeptide derived from ACTH, rigorously validated as a nootropic. Enhances focus, accelerates problem-solving, and provides neuroprotection against oxidative damage.

A synthetic tetrapeptide derived from the bovine pineal gland, sitting at the apex of life-extension bioscience. Studied for its ability to activate telomerase and reset the biological clock.

A potent growth hormone secretagogue that induces massive GH release with moderate appetite stimulation. Stronger than Ipamorelin but with more side effects.

A first-generation GH secretagogue known for intense appetite stimulation and powerful GH release. Favored in bulking protocols and for resolving chronic cachexia.

A 28-amino-acid thymic peptide approved as an orphan drug in 35+ countries. One of the most powerful immunomodulators, intelligently orchestrating immune responses rather than broadly boosting them.

A master anti-inflammatory tripeptide derived from alpha-MSH. Obliterates systemic inflammation at the genetic level without immunosuppression, making it a staple for IBD and gut health.

An endogenous cathelicidin antimicrobial peptide that serves as the immune system's first line of defense against bacteria, fungi, and biofilms including MRSA.

A neurohypophysial hormone FDA-approved for labor induction, widely studied for social bonding, anxiety reduction, and PTSD treatment via intranasal administration.

A long-acting GHRH analog that binds to blood albumin, providing continuous GH and IGF-1 elevation for over a week from a single injection.

A modified IGF-1 variant engineered to bypass growth-restricting transport proteins. Up to three times more potent than native IGF-1 for muscle hyperplasia.

The most potent synthetic GH secretagogue, with unique cardioprotective properties. Known for rapid receptor desensitization requiring strict 4–6 week cycling.

A naturally occurring nonapeptide that resets circadian rhythm and forces the brain into deep slow-wave (delta) sleep. Not a sedative but a master sleep regulator.

A powerful myostatin inhibitor that removes biological limits on muscle growth. Stimulates muscle hyperplasia beyond normal genetic potential.

A synthetic angiotensin IV analog with synaptic formation potency 10 million times stronger than BDNF. The ultimate heavyweight nootropic for cognitive enhancement.

A mitochondrial-derived peptide dubbed an 'exercise mimetic' that reverses age-related insulin resistance and enhances fat oxidation even in sedentary individuals.

An isolated C-terminal fragment of human growth hormone engineered to deliver pure fat-burning without growth-promoting or diabetogenic effects.

A concentrated neuropeptide mixture derived from porcine brain tissue, approved in 40+ countries for stroke recovery, TBI, and dementia. Forces actual physical neurogenesis.

The bioidentical synthetic equivalent of GnRH, used to preserve testicular volume and spermatogenesis during TRT. Requires pulsatile dosing.

A daily GLP-1 receptor agonist FDA-approved for diabetes (Victoza) and obesity (Saxenda). Favored when rapid dosage titration is needed.

A once-weekly GLP-1 receptor agonist FDA-approved for Type 2 diabetes with cardiovascular risk reduction. Engineered with monoclonal antibody technology.

A small-molecule NNMT inhibitor that disrupts fat storage at the cellular level, reversing diet-induced metabolic slowdown and shrinking fat cells.

An FDA/EMA-approved synthetic alpha-MSH analog that stimulates protective skin pigmentation. Used clinically for Erythropoietic Protoporphyria (EPP).

A mitochondria-targeted tetrapeptide that stabilizes the inner membrane to halt age-related energy decline. In clinical trials for heart failure and rare mitochondrial diseases.

The body's master antioxidant — an endogenous tripeptide critical for liver detoxification and cellular defense. Levels decline with age and toxin exposure.

A chemically stabilized variant of Selank with dramatically longer half-life and deeper blood-brain barrier penetration for enhanced anxiolytic and cognitive effects.

The upstream master switch of the reproductive HPG axis. The cleanest method to restore endogenous testosterone and support fertility without HPTA suppression.

The purified trans-isomer of Clomid, regarded as the premier SERM for male testosterone optimization. Forces massive endogenous testosterone production without testicular shrinkage.

The complete 43-amino-acid parent molecule from which TB-500 is derived. The biological master of cellular repair and cytoskeletal regeneration.

A stabilized arginine salt form of BPC-157 designed for oral administration with improved gastric stability.

A senolytic peptide that selectively forces zombie (senescent) cells to self-destruct, reducing systemic inflammation and reversing aging markers.

A mitochondrial-derived peptide that protects against programmed cell death. Discovered in brains of Alzheimer's patients who resisted neural decay.

The premier topical 'Botox alternative' — a hexapeptide that reduces wrinkles by interrupting neural signaling to facial muscles.

The gold standard in structural dermal remodeling. Tricks the skin into overproducing collagen by mimicking wound signals.

A PEGylated version of MGF with extended systemic half-life, enabling whole-body muscle repair from a single injection.

The body's natural 'first responder' peptide generated when muscle fibers suffer mechanical overload. Requires localized injection due to ultra-short half-life.

A neurogenic peptide derived from CNTF that promotes hippocampal neurogenesis and clears amyloid plaques, targeting Alzheimer's and TBI recovery.

A dual GLP-1/glucagon agonist with near 19% weight loss in Phase 3 trials, also targeting MASH liver disease.

A fixed-ratio combination of cagrilintide and semaglutide achieving 25%+ weight reduction by dual-pathway suppression of hunger centers.

An ultra-long-acting amylin analog that suppresses appetite via a pathway distinct from GLP-1, designed to shatter weight loss plateaus.

The first oral non-peptide GLP-1 receptor agonist. A daily pill achieving near-injectable weight loss results without needles.

A dual GLP-1/glucagon agonist developed in China, achieving 15–18% weight loss that rivals tirzepatide in Phase 3 trials.

A dual GLP-1/glucagon agonist built specifically to target and eliminate liver fat while driving 15%+ systemic weight loss.

An aggressive peptidomimetic that eradicates white fat by destroying the blood supply feeding fat cells. Carries severe renal toxicity risk.

An activin receptor decoy that blocks myostatin and related ligands to promote significant muscle growth. Studied for muscular dystrophy.

A legendary polypeptide bioregulator from Soviet military research that regenerates the involuted thymus gland and extends lifespan.

An endogenous 28-amino-acid neuropeptide that serves as the master regulator of immunity and vascular tone. Definitive intervention for CIRS and mold toxicity.

An EPO-derived peptide that reverses neuropathy without stimulating red blood cell production. The gold standard for small-fiber nerve repair.

A gut-trophic peptide that promotes intestinal mucosal growth and repair. Studied for short bowel syndrome and inflammatory bowel disease.

A spadin analog studied for rapid antidepressant-like effects, working through TREK-1 potassium channel modulation.

A triple monoamine reuptake inhibitor that reduces appetite and increases thermogenesis through central nervous system pathways.

A synthetic ERRγ agonist hailed as an exercise mimetic that replicates endurance training adaptations without physical exertion.

An AMPK activator studied for endurance enhancement and metabolic effects. Sometimes called an exercise-in-a-pill compound.

A potent GnRH agonist used for prostate cancer suppression and as a single-shot HPTA restart protocol after prolonged steroid use.

An FDA-approved MC4R agonist exclusively for patients with rare genetic obesity mutations (POMC, PCSK1, or LEPR deficiencies).

The first GLP-1 agonist ever, discovered in Gila monster venom. Laid the groundwork for the entire modern incretin weight loss era.

A fast-acting once-daily GLP-1 agonist specifically targeting post-meal blood sugar spikes, often combined with basal insulin.

The synthetic amylin analog FDA-approved as adjunctive therapy with insulin, the biochemical forerunner to cagrilintide.

A synthetic vasopressin analog with enhanced antidiuretic potency and no vasoconstrictive effects. Clinical standard for diabetes insipidus and hemophilia A.

The body's survival nonapeptide — used as a final-line hemodynamic rescue agent in septic shock and vasodilatory collapse.

A potent GnRH agonist used for prostate cancer, endometriosis, precocious puberty, and gender-affirming hormone suppression.

The synthetic ACTH(1-24) fragment used as the clinical gold standard to test adrenal cortisol-producing capacity (ACTH stimulation test).

The only FDA-approved oral treatment for interstitial cystitis (IC), acting as a biological mucosal sealant for the bladder wall.

A tight-junction regulator and zonulin antagonist developed for celiac disease, physically sealing the 'leaky gut' at its mechanical root cause.

A truncated IGF-1 variant with enhanced receptor binding affinity due to removal of the first three amino acids.

Peptides or proteins that block myostatin (GDF-8), a negative regulator of muscle growth, to allow increased muscle hypertrophy.

The 'Golden Ratio' of clinical anti-aging: a GHRH + GHRP combination that produces synergistic GH release exceeding either peptide alone.

The next-generation evolution of Argireline with two additional amino acids for deeper, more enduring anti-wrinkle efficacy.

A skin-lightening peptide that inhibits melanin production for even skin tone without the toxicity of hydroquinone.

An FDA-approved oral ghrelin receptor agonist used as a diagnostic tool for adult growth hormone deficiency.

A potent oral GH secretagogue that reached Phase II clinical trials. Though shelved commercially, it remains a testament to oral secretagogue engineering.

The endogenous 28-amino-acid hunger hormone from which all synthetic GHRPs are derived. Used to treat cancer cachexia and gastroparesis.

A pharmaceutical-grade neuropeptide complex from cerebral cortex tissue, deployed for stroke, TBI, and pediatric neurodevelopmental delays.

An endogenous neuro-dipeptide with non-opioid analgesic properties and anti-amyloid activity, studied for pain management and Alzheimer's.

A potent antimicrobial peptide fragment from bovine lactoferrin with broad-spectrum activity against bacteria, fungi, and some tumor cells.

An endogenous antimicrobial peptide from human neutrophils that shreds bacterial membranes and bridges innate-to-adaptive immune memory.

The natural Cytomax extraction from pineal glands, the raw predecessor to synthetic Epitalon. Used in Khavinson's landmark 15-year human longevity studies.

A Khavinson tripeptide bioregulator for brain cortex modulation, circadian rhythm restoration, and neuroprotection against oxidative aging.

An ultra-short Khavinson dipeptide that reverses thymic involution, re-establishing youthful immune function in aging populations.

A broad-spectrum immune bioregulator that recalibrates exhausted immune systems across bone marrow and spleen.

A tetrapeptide bioregulator for hepatic regeneration and epigenetic reprogramming, proven to decondense heterochromatin in elderly individuals.

A tetrapeptide bioregulator for pancreatic function, designed to salvage beta-cells and restore insulin regulation.

A Khavinson tripeptide for vascular intervention, restoring endothelial elasticity and reversing arterial hardening.

A tripeptide bioregulator for cartilage and joint regeneration, rebuilding joint matrix from the inside out.

A tetrapeptide bioregulator for cerebral cortex modulation, used in neuro-recovery protocols after stroke and cognitive decay.

A tripeptide bioregulator for pulmonary repair, targeting damaged bronchial and alveolar tissue.

A tetrapeptide bioregulator for bronchial function, prescribed for COPD, asthma, and post-viral lung scarring.

A tetrapeptide bioregulator for cardioprotection and myocardial recovery after heart failure or infarction.

A Khavinson tripeptide for male testicular function, restoring testosterone production and reversing Leydig cell senescence.

A Cytomax bioregulator for thyroid regeneration, preferred over synthetic T4/T3 for resolving age-related hypothyroidism.

The most critical immunological bioregulator, derived from youthful thymus tissue to reverse thymic involution and restore immune surveillance.

A synthetic dipeptide with intense thymopoietic activity, used to reconstruct destroyed immune systems post-radiation or immunosuppression.

The only known circulating thymic hormone, a zinc-dependent nonapeptide that crashes to zero with age as the thymus involutes.

A Cytomax bioregulator from liver and GI tissue for hepatic detoxification and digestive function restoration.

A Cytomax bioregulator for total skeletal and articular regeneration from cartilage and bone matrix extracts.

A Cytomax cardiac bioregulator for reversing hypertrophy, halting arrhythmias, and rebuilding failing myocardium.

A Cytomax vascular bioregulator for reducing arterial stiffness, reversing atherosclerosis, and normalizing hypertension.

The crown jewel of the Khavinson Cytomax line — the natural pineal extract predecessor to Epitalon for circadian and longevity restoration.

A Cytomax neuro-restorative complex from cerebral cortex tissue for cognitive decline reversal and CNS stress recovery.

A Cytomax bioregulator from skeletal muscle tissue for combating sarcopenia and accelerating recovery between training sessions.

A Cytomax adrenal bioregulator for HPA axis stabilization and recovery from chronic stress and burnout.

A Cytomax pulmonary bioregulator for deep respiratory regeneration after smoking, viral damage, or age-related decline.

A Cytomax hepatic bioregulator for liver rebuilding, toxicity reversal, and enzyme normalization.

A Cytomax renal bioregulator for halting nephropathy, restoring glomerular filtration, and protecting against hypertensive kidney damage.

A Cytomax ocular bioregulator for macular degeneration, diabetic retinopathy, and age-related vision decline.

A Cytomax retinal bioregulator for preserving visual acuity and defending against glaucoma and age-related macular degeneration.

A Cytomax bronchial bioregulator for airway damage repair and chronic bronchitis treatment.

A Cytomax gastric bioregulator for reversing atrophic gastritis and regenerating stomach mucosal barrier.

A Cytomax pancreatic bioregulator for full-spectrum pancreatic regeneration including exocrine enzyme and insulin output.

A Cytomax bladder bioregulator for urological restoration, calming hyperactive bladders and rebuilding detrusor muscle.

A pharmaceutical-grade retinal polypeptide delivered via parabulbar injection for diabetic retinopathy and age-related macular degeneration.

A Cytomax prostate bioregulator for chronic prostatitis, BPH, and post-surgical tissue repair.

A Cytomax bioregulator from bone marrow for treating anemia, post-chemotherapy recovery, and hematopoietic stem cell restoration.

A Cytomax parathyroid bioregulator for mineral balance, osteoporosis prevention, and arterial calcification defense.

A Cytomax prostate bioregulator for halting BPH, supporting urinary function, and restoring prostatic vitality.

A Cytomax testicular bioregulator for full-scope male endocrine rejuvenation including testosterone and spermatogenesis.

A Cytomax ovarian bioregulator for female longevity, delaying menopause and restoring ovarian endocrine capacity.